Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macrophage scavenger receptor types I and II, encoded by the MSR1 gene and also known as CD204, is a trimeric type II transmembrane glycoprotein primarily expressed on macrophages and dendritic cells. It functions as a pattern recognition receptor and scavenger receptor, mediating the endocytosis and phagocytosis of a wide range of macromolecules, including modified low-density lipoproteins (such as acetylated and oxidized LDL), apoptotic cell debris, and pathogens. MSR1 plays a dual role in various pathophysiological processes; it contributes to foam cell formation and atherogenesis in cardiovascular disease, but also aids in the clearance of amyloid-beta plaques in Alzheimer's disease. In oncology, MSR1 is highly expressed on immunosuppressive M2-like tumor-associated macrophages (TAMs), where its presence correlates with poor prognosis, tumor progression, and resistance to therapies. Consequently, MSR1 is being actively investigated as a biomarker for patient stratification and as a therapeutic target, both for direct inhibition to reprogram the tumor microenvironment and for receptor-mediated drug delivery using ligand-conjugated nanoparticles.
Ligand binding to MSR1 triggers receptor-mediated endocytosis and phagocytosis, leading to internalization and lysosomal degradation of ligands (such as modified lipoproteins, pathogens, or drug-loaded nanoparticles). It also modulates intracellular signaling pathways, including the JNK and PI3K/Akt pathways, which regulate macrophage polarization, inflammatory cytokine production, and cellular survival.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage scavenger receptor types I and II (MSR1).